HRVIX | SSGSX | HRVIX / SSGSX | |
Total Expense Ratio | 1.18 | 1.26 | 94% |
Annual Report Gross Expense Ratio | 1.18 | 1.26 | 94% |
Fund Existence | 31 years | 26 years | - |
Gain YTD | -17.611 | -15.873 | 111% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 244M | 5.23B | 5% |
Annual Yield % from dividends | 0.52 | 0.52 | 100% |
Returns for 1 year | -16.38 | -16.02 | 102% |
Returns for 3 years | -20.00 | -17.97 | 111% |
Returns for 5 years | 11.02 | 23.36 | 47% |
Returns for 10 years | 0.68 | 0.88 | 78% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FCIRX | 16.14 | 0.09 | +0.56% |
NYLI PineStone International Equity Cl A | |||
BIPSX | 17.39 | N/A | N/A |
ProFunds Biotechnology UltraSector Svc | |||
HDGYX | 33.02 | N/A | N/A |
Hartford Dividend and Growth Y | |||
RSEDX | 15.22 | N/A | N/A |
Columbia Large Cap Value Inst2 | |||
VRESX | 15.08 | N/A | N/A |
Virtus KAR Emerging Markets Small-Cap R6 |